Skip to main content

PEG-MGF vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

PEG-MGF

PEG-MGF (PEGylated Mechano Growth Factor) is a variant of IGF-1 that is produced in response to muscle damage. PEGylation extends its half-life from minutes to several hours, making it practical for use.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

AspectPEG-MGFIpamorelin
MechanismActivates muscle satellite cells (stem cells) and promotes their fusion to existing muscle fibers for repair and growth. MGF is produced naturally in response to mechanical stress on muscles.Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical DosageResearch protocols typically use 200-400mcg injected into targeted muscle groups 2-3 times weekly, usually post-workout.Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
AdministrationIntramuscular injection, ideally into muscles trained that day. Best administered post-workout when satellite cell activation is relevant.Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side EffectsInjection site soreness, potential hypoglycemia, and localized swelling. Generally well-tolerated.Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For

What They Have in Common

Both PEG-MGF and Ipamorelin are commonly used for:

Key Differences

Unique to Ipamorelin:

Detailed Analysis

Both Ipamorelin and PEG-MGF are commonly used for Muscle Growth, Recovery & Healing.

Which Should You Choose?

Ipamorelin has stronger evidence for Muscle Growth.

Ready to Learn More?